Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
to cancer immunotherapies and bone marrow transplantation. The candidate will evaluate and manage patients in Pulmonary ambulatory service lines, including the Pulmonary Consult Clinic and the Lung Cancer
-
Dalhousie University | Halifax Mid Harbour Nova Scotia Provincial Government, Nova Scotia | Canada | about 24 hours ago
: https://dal.peopleadmin.ca/postings/20087 Canada Impact+ Emerging Leaders Canada Impact+ Emerging Leaders are internationally recognized scholars in the early stages of their careers who are poised
-
Postdoc Appointment Term: 1-year term with possible extension Appointment Start Date: November 1, 2025 Group or Departmental Website: https://kalbasilab.org/ (link is external) How to Submit Application
-
antibody and CAR T cell immunotherapies for cancer is looking for an exceptionally motivated individual with past in vivo experience. The Smith Lab group is focused CAR T cell immunotherapy for cancer and
-
of immunity as well as develop innovative cellular immunotherapies against cancer. Being part of the Center for Hematology and Regenerative Medicine (HERM) and Center for Cellular Cancer Therapy (C33T) , we
-
Immunotherapy Program within the Division of Hematology/Oncology. The Clinical Research Coordinator will perform independently to execute, manage, and coordinate research protocols, as directed by the Clinical
-
Investigator, the Postdoctoral Associate will conduct research in the immunobiology of cancer and cancer immunotherapy. The research focuses on T cell differentiation and immune responses, with mechanistic
-
collaborative team of scientists dedicated to tumour antigen discovery and the development of next-generation immunotherapies. The group, led by Professor Nicola Ternette, investigates the role of HLA function in
-
of the lab is translational immunotherapy in prostate cancer. We are currently working closely with Dr. Robert Schreiber on the first trial of neoantigen vaccines in prostate cancer patients. Our lab